We are live on ! Find out more
TLOG

TetraLogic Pharmaceuticals Corporation
TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

Back to rankings

3 hedge funds and large institutions have $3K invested in TetraLogic Pharmaceuticals Corporation in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% less funds holding

Funds holding: 26 → 3 (-23)

98% less capital invested

Capital invested by funds: $146K → $3K (-$143K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 23

Holders
3
Holders Change
-23
Holders Change %
-88.46%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$30K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$25K
3
VKH
Virtu KCG Holdings
New York
-$17K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
1
California Public Employees Retirement System
California
$2K – – –
BWA
2
Burt Wealth Advisors
Maryland
$1K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
– -$30K -192,100 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$25K -157,349 Closed
VKH
5
Virtu KCG Holdings
New York
– -$17K -109,634 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
– -$13K -82,370 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
– -$12K -76,763 Closed
Goldman Sachs
8
Goldman Sachs
New York
– -$7K -44,131 Closed
Morgan Stanley
9
Morgan Stanley
New York
– -$6K -42,845 Closed
HighTower Advisors
10
HighTower Advisors
Illinois
– -$5K -27,870 Closed
Citadel Advisors
11
Citadel Advisors
Florida
– -$4K -27,442 Closed
UBS Group
12
UBS Group
Switzerland
– -$4K -27,299 Closed
GC
13
Guggenheim Capital
Illinois
– -$3K -21,405 Closed
TSS
14
Two Sigma Securities
New York
– -$3K -15,983 Closed
Northern Trust
15
Northern Trust
Illinois
– -$2K -12,716 Closed
Bank of New York Mellon
16
Bank of New York Mellon
New York
– -$2K -12,292 Closed
Creative Planning
17
Creative Planning
Kansas
– -$2K -12,102 Closed
MWP
18
MYCIO Wealth Partners
Pennsylvania
– -$2K -12,000 Closed
Wolverine Trading
19
Wolverine Trading
Illinois
– -$2K -10,200 Closed

TLOG Hedge Fund Activity: Q4 2016 in Review

3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q4 2016, worth a combined $3K — down 98% from $146K a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of TLOG and 0 opened new positions — a net loss of 23 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Renaissance Technologies, exiting entirely with an estimated $30K sold.

  • 3 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q4 2016, down from 26 in Q3 2016.
  • Funds reported $3K of TetraLogic Pharmaceuticals Corporation stock for Q4 2016, down 98% quarter-over-quarter.
  • 0 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q4 2016 and 23 closed out, a net change of -23 holders.
  • The largest TetraLogic Pharmaceuticals Corporation seller in Q4 2016 was Renaissance Technologies, an estimated $30K sold.

Based on aggregated 13F filings for Q4 2016.